| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.00022 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 3.7e-05 | 1 |